Privigen 100 mg/ml solution for infusion, Saline, 0.9% Sodium Chloride Solution for Injection, JNJ-80202135, JNJ-80202135
80202135CDP3001
Phase 2 small_molecule active
Quick answer
Privigen 100 mg/ml solution for infusion, Saline, 0.9% Sodium Chloride Solution for Injection, JNJ-80202135, JNJ-80202135 for Chronic Inflammatory Demyelinating Polyneuropathy is a Phase 2 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- Chronic Inflammatory Demyelinating Polyneuropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active